Shares of Antibe Therapeutics Inc. (TSE:ATE – Get Free Report) traded up 13.5% on Monday . The stock traded as high as C$0.35 and last traded at C$0.30. 167,044 shares changed hands during trading, an increase of 23% from the average session volume of 135,475 shares. The stock had previously closed at C$0.26.
Antibe Therapeutics Trading Up 13.5 %
The business’s 50-day simple moving average is C$0.30 and its two-hundred day simple moving average is C$0.60. The firm has a market capitalization of C$15.64 million, a price-to-earnings ratio of -0.84 and a beta of 0.19. The company has a quick ratio of 9.58, a current ratio of 10.06 and a debt-to-equity ratio of 0.29.
About Antibe Therapeutics
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
Further Reading
- Five stocks we like better than Antibe Therapeutics
- How to Invest in Insurance Companies: A Guide
- How to Invest in Silver: A Beginner’s Guide
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
